Biomaterial Database

Hormonal enteroinsular axis in newborn infants of insulin-treated diabetic mothers. 1993

M Knip, and P Kääpä, and M Koivisto

Department of Pediatrics, University of Oulu, Finland.

To study whether the increased glucose levels in the amniotic fluid during diabetic pregnancies induce an early maturation of the hormonal enteroinsular axis, we measured blood glucose levels and plasma concentrations of C-peptide, pancreatic glucagon, enteroglucagon, and gastric inhibitory polypeptide (GIP) in cord blood from 18 newborn infants of insulin-treated diabetic mothers (IDM) and 18 infants of nondiabetic mothers. In addition, we studied the same parameters in 20 IDM and 12 control infants before and after their first feed comprising human milk (5 mL/kg), given by nasogastric tube at the age of 2 h. The IDM had significantly higher blood glucose levels and plasma C-peptide concentrations in their cord blood than the control infants, which was followed postnatally by a substantial fall in these levels, whereas a more modest decrease could be seen in the control infants. Circulating enteroglucagon and GIP concentrations at the age of 2 h were significantly higher than those observed in cord blood in both the IDM and the control infants, but the IDM had significantly lower blood glucose levels, higher plasma C-peptide, and lower enteroglucagon concentrations before the first feed. There was a significant increase in blood glucose levels after the feed in both the IDM and the control infants, and the concentrations 2 h after feeding were of the same magnitude in the two groups. No significant C-peptide response could be observed in either group, but the IDM continuously had higher C-peptide concentrations. A significant enteroglucagon and GIP response could be seen in the IDM, whereas the controls exhibited only a GIP response. However, no significant differences were found between the two groups in the absolute postprandial plasma concentrations of these hormones. Our results show rapid, substantial postnatal changes in circulating concentrations of enteroinsular hormones in both IDM and control infants. Enteral feeding with human milk corrects early postnatal hypoglycemia within 2 h in most IDM without causing any exacerbation of their hyperinsulinemia. The absence of any C-peptide response to the first feed and of any observed differences between IDM and normal infants in absolute concentrations of enteroglucagon and GIP after the first feed suggests that the enteroinsular axis matures postnatally in both groups of infants.

UI	MeSH Term	Description	Entries
D007231	Infant, Newborn	An infant during the first 28 days after birth.	Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328	Insulin	A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).	Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515	Islets of Langerhans	Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN.	Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297	Male		Males
D008895	Milk, Human	Milk that is produced by HUMAN MAMMARY GLANDS.	Breast Milk,Human Milk,Milk, Breast
D010179	Pancreas	A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D011247	Pregnancy	The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	Gestation,Pregnancies
D011254	Pregnancy in Diabetics	The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.	Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic
D001786	Blood Glucose	Glucose in blood.	Blood Sugar,Glucose, Blood,Sugar, Blood
D002096	C-Peptide	The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.	Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide